loading

Axsome Therapeutics Inc Azioni (AXSM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
4.85%
75.00
71.53 57.79 46.70 94.58
Operating Expenses
16.21%
142.27
169.80 119.91 111.76 100.95
Benefits Costs and Expenses
15.92%
143.36
170.51 120.67 114.49 103.21
Costs And Expenses
16.21%
142.27
169.80 119.91 111.76 100.95
Operating Income/Loss
31.54%
-67.28
-98.27 -62.12 -65.06 -6.374
Income/Loss From Continuing Operations Before Tax
30.94%
-68.36
-98.98 -62.88 -67.79 -8.638
Income Tax Expense/Benefit
100.00%
-
-0.325 -0.678 -0.617 2.58
Income/Loss From Continuing Operations After Tax
30.71%
-68.36
-98.65 -62.20 -67.17 -11.22
Net Income/Loss
30.71%
-68.36
-98.65 -62.20 -67.17 -11.22
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7,284%
47.39
0.6418 47.12 43.67 43.52
Diluted Average Shares
7,284%
47.39
0.6418 47.12 43.67 43.52
Basic Earnings Per Share
32.39%
-1.44
-2.13 -1.32 -1.54 -0.26
Diluted Earnings Per Share
32.39%
-1.44
-2.13 -1.32 -1.54 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):